Vasodilator-stimulated phosphoprotein-guided Clopidogrel maintenance therapy reduces cardiovascular events in atrial fibrillation patients requiring anticoagulation therapy and scheduled for percutaneous coronary intervention: a prospective cohort study

BACKGROUND: In a previous study, we found that titrating clopidogrel maintenance doses (MDs) according to vasodilator-stimulated phosphoprotein (VASP) monitoring minimised the rate of major adverse cardiovascular and cerebral events (MACCE) after percutaneous coronary intervention (PCI) without incr...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Chaoyue, Zhang, Xumin, Liu, Yonghua, Gao, Yang, Zhao, Xiaohong, Zhou, Hua, Luo, Yu, Liu, Yaling, Wang, Xiaodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006722/
https://www.ncbi.nlm.nih.gov/pubmed/29914380
http://dx.doi.org/10.1186/s12872-018-0853-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006722/
https://www.ncbi.nlm.nih.gov/pubmed/29914380
http://dx.doi.org/10.1186/s12872-018-0853-x

Ejemplares similares